戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 was used to identify factors associated with HIV seropositivity.
2  SRPS (1.52, 1.13-2.04) were associated with HIV seropositivity.
3 s thereafter, participants were assessed for HIV seropositivity.
4 ription was associated with reduced rates of HIV seropositivity (adjusted risk ratio [RR] 0.63, 95% C
5                       Clinical outcomes were HIV seropositivity (all participants) and viral non-supp
6 vidence of a significant association between HIV seropositivity and OSSN.
7 ffered as a function of substance type used, HIV seropositivity, and BG subregion.
8 tent tuberculosis infection, hepatitis B and HIV seropositivity, and child and adult vaccination need
9                                    HSV-2 and HIV seropositivity are strong markers for high-risk sexu
10 n model included CM use, HbA1c, alcohol use, HIV seropositivity, BMI, and age, with robust performanc
11 cts (N = 101; 85 male, 16 female) with known HIV seropositivity for at least 6 months were randomized
12                                              HIV seropositivity (hazard ratio [HR], 2.68 [95% CI, 1.7
13                        In adjusted analyses, HIV seropositivity increased the hazard of death by 24%
14                             We conclude that HIV seropositivity is associated with a decline in respi
15   Despite adequate antiretroviral treatment, HIV seropositivity is associated with decreased survival
16      Correlates of HSV-2 seropositivity were HIV seropositivity, marital status, history of sexually
17          Conflicting evidence indicates that HIV seropositivity may influence the outcome of patients
18                   We estimated the effect of HIV seropositivity on patients' OS while accounting for
19 opositivity was notably associated with ever HIV seropositivity (OR [Odds Ratio] = 10.54, 95% CI [Con
20                                              HIV seropositivity was also negatively associated with b
21                                              HIV seropositivity was associated with worse outcomes ov
22                   In multivariable analyses, HIV seropositivity was independently associated with mor
23                   In multivariable analysis, HIV seropositivity was positively associated with older
24     No significant association was noted for HIV seropositivity with other phenotypes, but there was
25 thesized that comorbid polysubstance use and HIV seropositivity would alter BG GM volume differently